{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:42:18Z","timestamp":1792644138751,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018608","name":"National Program for Foreign Experts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005047","name":"Liaoning Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119301","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:52:18Z","timestamp":1788364338000},"page":"119301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MLI-DTA: An interpretable multimodal framework with multi-level interactions for drug-target affinity prediction"],"prefix":"10.1016","volume":"320","author":[{"given":"Yuning","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5115-8137","authenticated-orcid":false,"given":"Xiaohu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2026.119301_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.healthpol.2010.12.002","article-title":"The cost of drug development: a systematic review","volume":"100","author":"Morgan","year":"2011","journal-title":"Health Policy"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119301_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119301_bib3","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119301_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2017.31","article-title":"The high price of anticancer drugs: origins, implications, barriers, solutions","volume":"14","author":"Prasad","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.119301_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119301_bib6","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1162\/dint_a_00149","article-title":"Relational topology-based heterogeneous network embedding for predicting drug-target interactions","volume":"5","author":"Zhang","year":"2023","journal-title":"Data Intelligence"},{"issue":"5460","key":"10.1016\/j.ejmech.2026.119301_bib7","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.287.5460.1960","article-title":"Drug discovery: a historical perspective","volume":"287","author":"Drews","year":"2000","journal-title":"science"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119301_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"18","key":"10.1016\/j.ejmech.2026.119301_bib9","doi-asserted-by":"crossref","first-page":"i522","DOI":"10.1093\/bioinformatics\/bts383","article-title":"Relating drug\u2013protein interaction network with drug side effects","volume":"28","author":"Mizutani","year":"2012","journal-title":"Bioinformatics"},{"issue":"11","key":"10.1016\/j.ejmech.2026.119301_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nrd1549","article-title":"Docking and scoring in virtual screening for drug discovery: methods and applications","volume":"3","author":"Kitchen","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.ejmech.2026.119301_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaa430","article-title":"An end-to-end heterogeneous graph representation learning-based framework for drug\u2013target interaction prediction","volume":"22","author":"Peng","year":"2021","journal-title":"Briefings Bioinf."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119301_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41467-017-00680-8","article-title":"A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information","volume":"8","author":"Luo","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119301_bib13","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/bioinformatics\/bty543","article-title":"NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug\u2013target interactions","volume":"35","author":"Wan","year":"2019","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119301_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab275","article-title":"A heterogeneous network embedding framework for predicting similarity-based drug-target interactions","volume":"22","author":"An","year":"2021","journal-title":"Briefings Bioinf."},{"issue":"9","key":"10.1016\/j.ejmech.2026.119301_bib15","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1021\/acs.jmedchem.5b01684","article-title":"Role of molecular dynamics and related methods in drug discovery","volume":"59","author":"De Vivo","year":"2016","journal-title":"J. Med. Chem."},{"issue":"7805","key":"10.1016\/j.ejmech.2026.119301_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-020-2117-z","article-title":"An open-source drug discovery platform enables ultra-large virtual screens","volume":"580","author":"Gorgulla","year":"2020","journal-title":"Nature"},{"issue":"7873","key":"10.1016\/j.ejmech.2026.119301_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"nature"},{"issue":"13","key":"10.1016\/j.ejmech.2026.119301_bib18","doi-asserted-by":"crossref","first-page":"i509","DOI":"10.1093\/bioinformatics\/bty277","article-title":"Learning with multiple pairwise kernels for drug bioactivity prediction","volume":"34","author":"Cichonska","year":"2018","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.ejmech.2026.119301_bib19","doi-asserted-by":"crossref","first-page":"10947","DOI":"10.3390\/molecules200610947","article-title":"Low-quality structural and interaction data improves binding affinity prediction via random forest","volume":"20","author":"Li","year":"2015","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119301_bib20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/bib\/bbu010","article-title":"Toward more realistic drug\u2013target interaction predictions","volume":"16","author":"Pahikkala","year":"2015","journal-title":"Briefings Bioinf."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119301_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13321-017-0209-z","article-title":"SimBoost: a read-across approach for predicting drug\u2013target binding affinities using gradient boosting machines","volume":"9","author":"He","year":"2017","journal-title":"J. Cheminf."},{"issue":"17","key":"10.1016\/j.ejmech.2026.119301_bib22","doi-asserted-by":"crossref","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","article-title":"DeepDTA: deep drug\u2013target binding affinity prediction","volume":"34","author":"\u00d6zt\u00fcrk","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmech.2026.119301_bib23","article-title":"WideDTA: prediction of drug-target binding affinity","author":"\u00d6zt\u00fcrk","year":"2019","journal-title":"arXiv preprint arXiv:1902.04166"},{"issue":"2","key":"10.1016\/j.ejmech.2026.119301_bib24","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1109\/TCBB.2022.3170365","article-title":"AttentionDTA: drug\u2013target binding affinity prediction by sequence-based deep learning with attention mechanism","volume":"20","author":"Zhao","year":"2022","journal-title":"IEEE ACM Trans. Comput. Biol. Bioinf"},{"issue":"18","key":"10.1016\/j.ejmech.2026.119301_bib25","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/bioinformatics\/btz111","article-title":"DeepAffinity: interpretable deep learning of compound\u2013protein affinity through unified recurrent and convolutional neural networks","volume":"35","author":"Karimi","year":"2019","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.ejmech.2026.119301_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbab506","article-title":"FusionDTA: attention-based feature polymerizer and knowledge distillation for drug-target binding affinity prediction","volume":"23","author":"Yuan","year":"2022","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.ejmech.2026.119301_bib27","article-title":"Attention is all you need","volume":"30","author":"Vaswani","year":"2017","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.ejmech.2026.119301_bib28","article-title":"Semi-supervised classification with graph convolutional networks","author":"Kipf","year":"2016","journal-title":"arXiv preprint arXiv:1609.02907"},{"key":"10.1016\/j.ejmech.2026.119301_bib29","article-title":"Graph attention networks","author":"Veli\u010dkovi\u0107","year":"2017","journal-title":"arXiv preprint arXiv:1710.10903"},{"key":"10.1016\/j.ejmech.2026.119301_bib30","article-title":"How powerful are graph neural networks?","author":"Xu","year":"2018","journal-title":"arXiv preprint arXiv:1810.00826"},{"issue":"8","key":"10.1016\/j.ejmech.2026.119301_bib31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/bioinformatics\/btaa921","article-title":"GraphDTA: predicting drug\u2013target binding affinity with graph neural networks","volume":"37","author":"Nguyen","year":"2021","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.ejmech.2026.119301_bib32","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1039\/D1SC05180F","article-title":"MGraphDTA: deep multiscale graph neural network for explainable drug\u2013target binding affinity prediction","volume":"13","author":"Yang","year":"2022","journal-title":"Chem. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.119301_bib33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1021\/acs.jcim.4c01828","article-title":"MMSG-DTA: a multimodal, multiscale model based on sequence and graph modalities for drug-target affinity prediction","volume":"65","author":"Xu","year":"2025","journal-title":"J. Chem. Inf. Model."},{"issue":"10","key":"10.1016\/j.ejmech.2026.119301_bib34","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.3390\/ijms25105126","article-title":"Prediction of drug-target affinity using attention neural network","volume":"25","author":"Tang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119301_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2025.104926","article-title":"MF-DTA: predicting drug-target affinity with multi-modal feature fusion model","author":"Kang","year":"2025","journal-title":"J. Biomed. Inf."},{"issue":"7","key":"10.1016\/j.ejmech.2026.119301_bib36","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1109\/JBHI.2025.3553217","article-title":"Multi-modal deep representation learning accurately identifies and interprets drug-target interactions","volume":"29","author":"Hu","year":"2025","journal-title":"IEEE J. Biomed. Health Inform."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119301_bib37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12915-025-02456-9","article-title":"An interpretable geometric graph neural network for enhancing the generalizability of drug\u2013target interaction prediction","volume":"23","author":"Xiong","year":"2025","journal-title":"BMC Biol."},{"issue":"11","key":"10.1016\/j.ejmech.2026.119301_bib38","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nat. Biotechnol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.119301_bib39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/ci400709d","article-title":"Making sense of large-scale kinase inhibitor bioactivity data sets: a comparative and integrative analysis","volume":"54","author":"Tang","year":"2014","journal-title":"J. Chem. Inform. Model."},{"issue":"1","key":"10.1016\/j.ejmech.2026.119301_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41746-025-01464-x","article-title":"Dual modality feature fused neural network integrating binding site information for drug target affinity prediction","volume":"8","author":"He","year":"2025","journal-title":"npj Digital Med."}],"updated-by":[{"DOI":"10.1016\/j.ejmech.2026.119367","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000}},{"DOI":"10.1016\/j.ejmech.2026.119367","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,12,15]],"date-time":"2026-12-15T00:00:00Z","timestamp":1797292800000}}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426007464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:27:45Z","timestamp":1792643265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426007464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":40,"alternative-id":["S0223523426007464"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119301","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MLI-DTA: An interpretable multimodal framework with multi-level interactions for drug-target affinity prediction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119301"}}